Evidence map›Paper›PMID 34785639›Full record

ArticleTranslational psychiatry2021

Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk.

S I Dimitriadis, G Perry, S F Foley, K E Tansey, D K Jones, P Holmans, S Zammit, J Hall, M C O'Donovan, M J Owen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

S I DimitriadisNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK. DimitriadisS@cardiff.ac.uk.ORCID http://orcid.org/0000-0002-0000-5392
G PerryCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, CF24 4HQ, UK.
S F FoleyCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0002-8390-2709
K E TanseyMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
D K JonesCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, CF24 4HQ, UK.
P HolmansMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0003-0870-9412
S ZammitMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff School of Medicine, Cardiff University, Cardiff, CF24 4HQ, UK.
J HallNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0002-0403-3278
M C O'DonovanNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0001-7073-2379
M J OwenNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0003-4798-0862
K D SinghCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, College of Biomedical and Life Sciences, Cardiff University, Cardiff, CF24 4HQ, UK.ORCID http://orcid.org/0000-0002-3094-2475
D E LindenNeuroscience and Mental Health Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK.
Cardiff University · GBMaastricht University · NLUniversity of Bristol · GB

Funding

Medical Research Council MR/K004360/1Medical Research Council MR/L010305/1Wellcome TrustWellcome Trust 104943/Z/14/ZWellcome Trust (Wellcome) 096646/Z/11/Z
6 · The paper itself

Abstract

Gamma oscillations (30-90 Hz) have been proposed as a signature of cortical visual information processing, particularly the balance between excitation and inhibition, and as a biomarker of neuropsychiatric diseases. Magnetoencephalography (MEG) provides highly reliable visual-induced gamma oscillation estimates, both at sensor and source level. Recent studies have reported a deficit of visual gamma activity in schizophrenia patients, in medication naive subjects, and high-risk clinical participants, but the genetic contribution to such a deficit has remained unresolved. Here, for the first time, we use a genetic risk score approach to assess the relationship between genetic risk for schizophrenia and visual gamma activity in a population-based sample drawn from a birth cohort. We compared visual gamma activity in a group (N = 104) with a high genetic risk profile score for schizophrenia (SCZ-PRS) to a group with low SCZ-PRS (N = 99). Source-reconstructed V1 activity was extracted using beamformer analysis applied to MEG recordings using individual MRI scans. No group differences were found in the induced gamma peak amplitude or peak frequency. However, a non-parametric statistical contrast of the response spectrum revealed more robust group differences in the amplitude of high-beta/gamma power across the frequency range, suggesting that overall spectral shape carries important biological information beyond the individual frequency peak. Our findings show that changes in gamma band activity correlate with liability to schizophrenia and suggest that the index changes to synaptic function and neuronal firing patterns that are of pathophysiological relevance rather than consequences of the disorder.

Indexed as

SchizophreniaBirth CohortGamma RhythmHumansMagnetoencephalographyRisk Factors

Identifiers

PMID34785639
PMCPMC8595678
OpenAlexW3214513703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.